BackNingbo Menovo Pharmaceutical , Ltd. Overview

Ningbo Menovo Pharmaceutical , Ltd. EBIT

Latest ebit for 603538.SS: $160M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$46.60M
↓ 31.49% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$158.74M
↓ 16.16% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ningbo Menovo Pharmaceutical , Ltd. (603538.SS) FAQ

The latest EBIT for 603538.SS is $160M as of September 2026. That compares with $190M in the prior-year period — down 16.2% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Ningbo Menovo Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 603538.SS's EBIT moved from $190M to $160M — a 16.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ningbo Menovo Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

Against its sector companies, 603538.SS currently prints $160M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Ningbo Menovo Pharmaceutical , Ltd.'s growth, margins, and balance sheet.

A EBIT figure of $160M for 603538.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting 603538.SS's EBIT ($160M), review year-over-year change from $190M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.